Mindfulness-based interventions for breast cancer patients in China across outcome domains: a systematic review and meta-analysis of the Chinese literature

Shi-jie, Jing; Zhang, Anao; Chen, Yuying; Shen, Changyi; Currin‐McCulloch, Jennifer; Zhu, Chenfang

doi:10.1007/s00520-021-06166-0

Cited by 12 publications

(6 citation statements)

References 43 publications

(39 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The use of adjuvant therapies based on behavioral or psychological interventions, such as music therapy, mindfulness, RE: estrogen receptor; HER2: human epidermal growth factor receptor type 2; RE: estrogen receptor; HER2: human epidermal growth factor receptor type 2; *doxorubicin (60 mg/m²) and cyclophosphamide (600 mg/m²), every 3 weeks; **doxorubicin (60 mg/m²) and cyclophosphamide (600 mg/m²), every 2 weeks. acupuncture, inhaled aromatherapy, and hypnosis, can help control anticipatory symptoms 9,10,[16][17][18][19] , which reinforces the role of psychological processes in the emergence of these symptoms.…”

Section: Discussionmentioning

confidence: 99%

Prevalence of anticipatory nausea and vomiting in breast cancer patients undergoing highly emetogenic chemotherapy

Alves,

Rebouças,

Yamada

et al. 2024

Rev. Assoc. Med. Bras.

View full text Add to dashboard Cite

OBJECTIVE: Anticipatory nausea and vomiting are unpleasant symptoms observed before undergoing chemotherapy sessions. Less is known about the occurrence of symptoms since the advent of the new neurokinin-1 antagonist. METHODS: This prospective cohort study was performed at a single Brazilian Institution. This study included breast cancer patients who received doxorubicin and cyclophosphamide chemotherapy and an appropriate antiemetic regimen (dexamethasone 10 mg, palonosetron 0.56 mg, and netupitant 300 mg in the D1 followed by dexamethasone 10 mg 12/12 h in D2 and D4). Patients used a diary to record nausea, vomiting, and use of rescue medication in the first two cycles of treatment. The prevalence of anticipatory nausea and vomiting was assessed before chemotherapy on day 1 of C2. RESULTS: From August 4, 2020, to August 12, 2021, 60 patients were screened, and 52 patients were enrolled. The mean age was 50.8 (28-69) years, most had stage III (53.8%), and most received chemotherapy with curative intent (94%). During the first cycle, the frequency of overall nausea and vomiting was 67.31%, and that of severe nausea and vomiting (defined as grade>4 on a 10-point visual scale or use of rescue medication) was 55.77%. Ten patients had anticipatory nausea and vomiting (19.23%). The occurrence of nausea and vomiting during C1 was the only statistically significant predictor of anticipatory nausea and vomiting (OR=16, 95%CI 2.4-670.9, p=0.0003). CONCLUSION: The prevalence of anticipatory nausea is still high in the era of neurokinin-1 antagonists, and failure of antiemetic control in C1 remains the main risk factor. All efforts should be made to control chemotherapy-induced nausea or nausea and vomiting on C1 to avoid anticipatory nausea.

show abstract

Section: Discussionmentioning

confidence: 99%

Prevalence of anticipatory nausea and vomiting in breast cancer patients undergoing highly emetogenic chemotherapy

Alves,

Rebouças,

Yamada

et al. 2024

Rev. Assoc. Med. Bras.

View full text Add to dashboard Cite

show abstract

“…Mindfulness-based interventions can effectively relieve stress, improve mental states including anxiety and depression, and improve the quality of life in breast cancer patients ( Kenne Sarenmalm et al, 2017 ; Priya and Kalra, 2018 ). Jing et al (2021) reported that mindfulness-based intervention improved overall outcomes among Chinese breast cancer patients. Recent research showed that a mindfulness-based stress reduction approach, group counseling, and survivorship education could reduce depressive symptoms in young breast cancer survivors ( Mirmahmoodi et al, 2020 ; Bower et al, 2021 ; Printz, 2021 ).…”

Section: Discussionmentioning

confidence: 99%

Global trends of research on depression in breast cancer: A bibliometric study based on VOSviewer

et al. 2022

View full text Add to dashboard Cite

BackgroundDepression is common psychiatric morbidity in breast cancer survivors, seriously affecting patients’ quality of life and mental health. A growing body of research has investigated depression in breast cancer. However, no visual bibliometric analysis was conducted in this field. This study aimed to visualize the literature to identify hotspots and frontiers in research on breast cancer and depression.MethodsThe publications related to depression in breast cancer were retrieved in the Web of Science Core Collection between 1 January 2002 and 17 March 2022. VOSviewer was used to identify co-occurrences and collaborations among countries, institutions, and keywords. CiteSpace was used to detect keyword bursts.ResultsA total of 7,350 articles and reviews related to depression in breast cancer were identified. From 2002 to 2022, the United States and the People’s Republic of China were the most productive countries in this field. The University of California, Los Angeles, and the University of Toronto were the most productive institutions in this field. The Journal of Psycho-oncology, followed by Supportive Care in Cancer and the Journal of Clinical Oncology, had the most publications on depression in breast cancer. Of the top 10 journals, seven were from the United States, two were from England, and one was from Germany. Five research hotspots of depression in breast cancer were identified by co-word analysis. Research on post-traumatic growth, spiritual interventions, cognitive-behavioral therapy, physical activity, and symptom cluster management of depression in breast cancer was relatively mature in the core hotspots. Burst detection of keywords on depression in breast cancer showed the latest hotspots, such as mental health, cancer survivor mortality, and activity.ConclusionThe research on depression in breast cancer is growing. Attention should be paid to the latest hotspots, such as mental health, cancer survivor, mortality, exercise, and physical activity.

show abstract

“…Some studies believe that patients with higher levels of mindfulness can more quickly accept negative physical and mental problems during treatment, and form rational thinking patterns through "self-awareness" to relieve negative feelings. [27] It is suggested that clinical staffs can set up mindfulness cultivation programs to prevention the demoralization syndrome among cancer patients.…”

Section: Mindfulness Has a Negative Predictive Effect On Demoralizati...mentioning

confidence: 99%

The mediating effect of mindfulness on demoralization syndrome and quality of life of thyroid cancer patients: A correlational study

Li¹,

Zhao²,

JingJun³

2023

Medicine

View full text Add to dashboard Cite

Demoralization syndrome is prevalence among cancer patients in China. However, little research has examined how demoralization syndrome is associated with quality of life (QOL). The aims of this study were to investigate the relationship between mindfulness state, demoralization syndrome and QOL of thyroid cancer patients, and explore the mediating effect of mindfulness on demoralization syndrome and QOL. A correlational cross-sectional study was performed using an online questionnaire. The study was conducted from July to October 2022 among 310 thyroid cancer patients. General information questionnaire, the Demoralization Scale, Five Facet Mindfulness Questionnaire, short form health survey questionnaire were used for investigation. Calculations were performed using SPSS Statistics, version 25. Descriptive statistics, correlation, and process plug-in mediation effect analyses were used to analyze the data. A total of 310 valid questionnaires were finally recovered. The Five Facet Mindfulness Questionnaire score of 310 patients was (120.80 ± 16.57), Demoralization Scale score was (12.49 ± 4.73), short form health survey questionnaire score was (146.15 ± 28.46). Mindfulness played a partial mediating role between demoralization syndrome and QOL of thyroid cancer patients, and the mediating effect accounted for 68.57% of the total effect. Demoralization syndrome can influence QOL through mindfulness state. Measures are needed to increase the QOL of thyroid cancer patients by developing mindfulness programs to decrease their demoralization syndrome.

show abstract

Mindfulness-based interventions for breast cancer patients in China across outcome domains: a systematic review and meta-analysis of the Chinese literature

Cited by 12 publications

References 43 publications

Prevalence of anticipatory nausea and vomiting in breast cancer patients undergoing highly emetogenic chemotherapy

Prevalence of anticipatory nausea and vomiting in breast cancer patients undergoing highly emetogenic chemotherapy

Global trends of research on depression in breast cancer: A bibliometric study based on VOSviewer

The mediating effect of mindfulness on demoralization syndrome and quality of life of thyroid cancer patients: A correlational study

Contact Info

Product

Resources

About